Edwards Lifesciences Corp (NYSE:EW)
$ 90.25 0.47 (0.52%) Market Cap: 54.38 Bil Enterprise Value: 53.11 Bil PE Ratio: 38.90 PB Ratio: 7.64 GF Score: 98/100

Edwards Lifesciences Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 14, 2019 / 09:20PM GMT
Release Date Price: $59.63 (+0.40%)
Unidentified Analyst

This is really meant to be entirely Q&A. So Scott, thank you for being here.

Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO

My pleasure.

Unidentified Analyst

If there's any kind of overarching message you want to get across, fine. Otherwise, we can just jump right into it.

Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO

Well, maybe I'll just make some overview comments to get us started. A couple of things. One, we're off to a good start this year. I think we feel very confident about the future of our therapies aimed at treating aortic stenosis.

And a couple of things have happened early on. One is we saw these extraordinary results of the PARTNER 3 trial looking at patients who were at low risk of undergoing traditional open heart surgery. And that trial showed superiority over traditional open heart surgery. The second element, I guess, is we continue to see just dramatic undertreatment of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot